WT1 Dendritic Cell Vaccine Therapy Improves Immune Profile and Prolongs Progression-Free Survival in End-Stage Lung Cancer

被引：4
|
作者：
Nagai, Hisashi [1 ,2 ]
Karube, Ryusuke [1 ]
机构：
[1] Ginza Phoenix Clin, Oncol, Tokyo, Japan
[2] Tokai Univ, Grad Sch Human & Environm Studies, Tokyo, Japan
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 10期
关键词：
wt1; progression-free survival; chemotherapy response; cancer immunotherapy; immune profile; metastatic non-small cell lung cancer; dendritic cell; MEDIATED CYTOTOXICITY; IMMUNOTHERAPY; NEUTROPHIL;
D O I：
10.7759/cureus.47320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
WT1-pulsed dendritic cell (WT1-DC) therapy was performed for end-stage squamous cell lung cancer that rapidly worsened soon after completion of carboplatin and paclitaxel. A rapid improvement in immune profile was observed with the initiation of WT1-DC. Docetaxel and ramucirumab were initiated as second -line agents during WT1-DC. The improvement of the immune profile status continued, and at the same time, the cancer showed a predominant shrinkage. Progression-free survival was over 577 days, and the patient was able to lead a normal daily life with a performance status of 1. These findings suggest that WT1-DC improves the immune profile, and this may contribute to the long-lasting and sustained effect of chemotherapy.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Radioimmunotherapy With WT1 Dendritic Cell Vaccine for End-Stage Lung Adenocarcinoma Markedly Shrinks Tumors
    Nagai, Hisashi
    Karube, Ryusuke
    Zhao, Fengxiang
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [2] Combination of Radiation Therapy, Wim's Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer
    Nagai, Hisashi
    Chen, Hao
    Karube, Ryusuke
    Koitabashi, Yusuke
    Numata, Ouka
    Yamahara, Kenichi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [3] Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer
    Komaki, Ritsuko
    Allen, Pamela K.
    Wei, Xiong
    Blumenschein, George R.
    Tang, Ximing
    Lee, J. Jack
    Welsh, James W.
    Wistuba, Ignacio I.
    Liu, Diane D.
    Hong, Waun Ki
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 317 - 324
  • [4] Stereotactic Ablative Radiation Therapy Improves Progression-free Survival and Local Control In Patients with Oligometastatic Lung Cancer
    Blake, M.
    Maldonado, F.
    De la Mata, D.
    Gerson, R.
    Flores, F.
    Barron, F.
    Butler, E. B.
    Teh, B. S.
    Pino, R.
    Hernandez-Bojorquez, M.
    Corona, F.
    Flores, D.
    Arrieta, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E675 - E675
  • [5] Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study
    Nishida, Sumiyuki
    Ishikawa, Takeshi
    Egawa, Shinichi
    Koido, Shigeo
    Yanagimoto, Hiroaki
    Ishii, Jun
    Kanno, Yoshihide
    Kokura, Satoshi
    Yasuda, Hiroaki
    Oba, Mari Saito
    Sato, Maho
    Morimoto, Soyoko
    Fujiki, Fumihiro
    Eguchi, Hidetoshi
    Nagano, Hiroaki
    Kumanogoh, Atsushi
    Unno, Michiaki
    Kon, Masanori
    Shimada, Hideaki
    Ito, Kei
    Homma, Sadamu
    Oka, Yoshihiro
    Morita, Satoshi
    Sugiyama, Haruo
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (03) : 320 - 331
  • [6] WT1 AND MUC1-PULSED DENDRITIC CELL VACCINATION THERAPY FOR NON-SMALL-CELL LUNG CANCER
    Kobayashi, Takashi
    Koizumi, Tomonobu
    Tateishi, Kazunari
    Urushihata, Kazuhisa
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Kubo, Keishi
    Shimodaira, Shigetaka
    Yanagisawa, Ryu
    Muramatsu, Saori
    Higuchi, Yumiko
    Goto, Takahumi
    Ishikawa, Shinsuke
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1266 - S1267
  • [7] Progression-free survival in ovarian cancer patients in second remission with mucin-1 autologous dendritic cell therapy.
    Gray, Heidi J.
    Gargosky, Sharron Erna
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study
    Chen, Xin-Ru
    Liang, Jian-Zhong
    Ma, Shu-Xiang
    Fang, Wen-Feng
    Zhou, Ning-Ning
    Liao, Hai
    Li, De-Lan
    Chen, Li-Kun
    ONCOTARGETS AND THERAPY, 2016, 9 : 5729 - 5736
  • [9] Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy
    Bhatt, P.
    Bonomi, P.
    Basu, S.
    Batus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S868 - S869
  • [10] Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer
    Foster, Nathan R.
    Renfro, Lindsay A.
    Schild, Steven E.
    Redman, Mary W.
    Wang, Xiaofei F.
    Dahlberg, Suzanne E.
    Ding, Keyue
    Bradbury, Penelope A.
    Ramalingam, Suresh S.
    Gandara, David R.
    Shibata, Taro
    Saijo, Nagahiro
    Vokes, Everett E.
    Adjei, Alex A.
    Mandrekar, Sumithra J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) : 1099 - 1106
12345